223 related articles for article (PubMed ID: 16919461)
21. Design, synthesis and evaluation of a novel cyclohexanamine class of neuropeptide Y Y1 receptor antagonists.
Cho K; Ando M; Kobayashi K; Miyazoe H; Tsujino T; Ito S; Suzuki T; Tanaka T; Tokita S; Sato N
Bioorg Med Chem Lett; 2009 Aug; 19(16):4781-5. PubMed ID: 19596193
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and structure-activity relationship of N-(3-azabicyclo[3.1.0]hex-6-ylmethyl)-5-(2-pyridinyl)-1,3-thiazol-2-amines derivatives as NPY Y5 antagonists.
Biagetti M; Leslie CP; Mazzali A; Seri C; Pizzi DA; Bentley J; Genski T; Di Fabio R; Zonzini L; Caberlotto L
Bioorg Med Chem Lett; 2010 Aug; 20(16):4741-4. PubMed ID: 20630754
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and SAR of a novel series of benzimidazoles as potent NPY Y5 antagonists.
Pizzi DA; Leslie CP; Mazzali A; Seri C; Biagetti M; Bentley J; Genski T; Di Fabio R; Contini S; Sabbatini FM; Zonzini L; Caberlotto L
Bioorg Med Chem Lett; 2010 Dec; 20(23):7120-3. PubMed ID: 20951033
[TBL] [Abstract][Full Text] [Related]
24. [Design, synthesis and vasorelaxant activity of R, S-1-(substituted phenyl)-4-[3-(naphtha-1-yl-oxy)-2-hydroxypropyl]-piperazine derivatives].
Fu XZ; Tang L; Yuan M; Shi JS
Yao Xue Xue Bao; 2007 Jul; 42(7):735-40. PubMed ID: 17882957
[TBL] [Abstract][Full Text] [Related]
25. Aryl urea derivatives of spiropiperidines as NPY Y5 receptor antagonists.
Takahashi T; Haga Y; Sakamoto T; Moriya M; Okamoto O; Nonoshita K; Shibata T; Suga T; Takahashi H; Hirohashi T; Sakuraba A; Gomori A; Iwaasa H; Ohe T; Ishihara A; Ishii Y; Kanatani A; Fukami T
Bioorg Med Chem Lett; 2009 Jul; 19(13):3511-6. PubMed ID: 19464889
[TBL] [Abstract][Full Text] [Related]
26. Modeling of neuropeptide receptors Y1, Y4, Y5, and docking studies with neuropeptide antagonist.
Jois SD; Nagarajarao LM; Prabhakaran M; Balasubramaniam A
J Biomol Struct Dyn; 2006 Apr; 23(5):497-508. PubMed ID: 16494499
[TBL] [Abstract][Full Text] [Related]
27. Discovery of pyridone-containing imidazolines as potent and selective inhibitors of neuropeptide Y Y5 receptor.
Ando M; Sato N; Nagase T; Nagai K; Ishikawa S; Takahashi H; Ohtake N; Ito J; Hirayama M; Mitobe Y; Iwaasa H; Gomori A; Matsushita H; Tadano K; Fujino N; Tanaka S; Ohe T; Ishihara A; Kanatani A; Fukami T
Bioorg Med Chem; 2009 Aug; 17(16):6106-22. PubMed ID: 19616955
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and serotonergic activity of variously substituted (3-amido)phenylpiperazine derivatives and benzothiophene-4-piperazine derivatives: novel antagonists for the vascular 5-HT1B receptor.
Moloney GP; Garavelas A; Martin GR; Maxwell M; Glen RC
Eur J Med Chem; 2004 Apr; 39(4):305-21. PubMed ID: 15072840
[TBL] [Abstract][Full Text] [Related]
29. A novel range based QSAR study of human neuropeptide Y (NPY) Y5 receptor inhibitors.
Deswal S; Roy N
Eur J Med Chem; 2007 Apr; 42(4):463-70. PubMed ID: 17083999
[TBL] [Abstract][Full Text] [Related]
30. Functional characterization of human neuropeptide Y receptor subtype five specific antagonists using a luciferase reporter gene assay.
Beauverger P; Rodriguez M; Nicolas JP; Audinot V; Lamamy V; Dromaint S; Nagel N; Macia C; Léopold O; Galizzi JP; Caignard DH; Aldana I; Monge A; Chomarat P; Boutin JA
Cell Signal; 2005 Apr; 17(4):489-96. PubMed ID: 15601626
[TBL] [Abstract][Full Text] [Related]
31. Quantitative structure activity relationship of benzoxazinone derivatives as neuropeptide Y Y5 receptor antagonists.
Deswal S; Roy N
Eur J Med Chem; 2006 Apr; 41(4):552-7. PubMed ID: 16545499
[TBL] [Abstract][Full Text] [Related]
32. Novel potent antagonists of human neuropeptide Y Y5 receptors. Part 3: 7-methoxy-1-hydroxy-1-substituted tetraline derivatives.
Itani H; Ito H; Sakata Y; Hatakeyama Y; Oohashi H; Satoh Y
Bioorg Med Chem Lett; 2002 Mar; 12(5):799-802. PubMed ID: 11859006
[TBL] [Abstract][Full Text] [Related]
33. Novel orally active NPY Y5 receptor antagonists: Synthesis and structure-activity relationship of spiroindoline class compounds.
Sakamoto T; Moriya M; Tsuge H; Takahashi T; Haga Y; Nonoshita K; Okamoto O; Takahashi H; Sakuraba A; Hirohashi T; Shibata T; Kanno T; Ito J; Iwaasa H; Gomori A; Ishihara A; Fukuroda T; Kanatani A; Fukami T
Bioorg Med Chem; 2009 Jul; 17(14):5015-26. PubMed ID: 19525116
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and identification of novel benzimidazole derivatives as highly potent NPY Y5 receptor antagonists with attractive in vitro ADME profiles.
Tamura Y; Omori N; Kouyama N; Nishiura Y; Hayashi K; Watanabe K; Tanaka Y; Chiba T; Yukioka H; Sato H; Okuno T
Bioorg Med Chem Lett; 2012 Sep; 22(17):5498-502. PubMed ID: 22853998
[TBL] [Abstract][Full Text] [Related]
35. Structure-activity relationships of a series of pyrrolo[3,2-d]pyrimidine derivatives and related compounds as neuropeptide Y5 receptor antagonists.
Norman MH; Chen N; Chen Z; Fotsch C; Hale C; Han N; Hurt R; Jenkins T; Kincaid J; Liu L; Lu Y; Moreno O; Santora VJ; Sonnenberg JD; Karbon W
J Med Chem; 2000 Nov; 43(22):4288-312. PubMed ID: 11063624
[TBL] [Abstract][Full Text] [Related]
36. Novel human neuropeptide Y Y5 receptor antagonists for the treatment of obesity. Synthesis and biological evaluation of pyridine hydrazide derivatives.
Galiano S; Erviti O; Pérez S; Moreno A; Juanenea L; Aldana I; Monge A
Arzneimittelforschung; 2005; 55(2):81-5. PubMed ID: 15787274
[TBL] [Abstract][Full Text] [Related]
37. Novel potent antagonists of human neuropeptide Y Y5 receptors. Part 2: substituted benzo[a]cycloheptene derivatives.
Itani H; Ito H; Sakata Y; Hatakeyama Y; Oohashi H; Satoh Y
Bioorg Med Chem Lett; 2002 Mar; 12(5):757-61. PubMed ID: 11858996
[TBL] [Abstract][Full Text] [Related]
38. Novel potent antagonists of human neuropeptide Y-Y5 receptor. Part 4: tetrahydrodiazabenzazulene derivatives.
Satoh Y; Hatori C; Ito H
Bioorg Med Chem Lett; 2002 Apr; 12(7):1009-11. PubMed ID: 11909705
[TBL] [Abstract][Full Text] [Related]
39. Novel non-peptidic neuropeptide Y Y2 receptor antagonists.
Jablonowski JA; Chai W; Li X; Rudolph DA; Murray WV; Youngman MA; Dax SL; Nepomuceno D; Bonaventure P; Lovenberg TW; Carruthers NI
Bioorg Med Chem Lett; 2004 Mar; 14(5):1239-42. PubMed ID: 14980673
[TBL] [Abstract][Full Text] [Related]
40. Preparation of fluorescent nonpeptidic neuropeptide Y receptor ligands: analogues of the quinazoline-type anti-obesity Y5 antagonist CGP 71683A.
Li L; Mayer M; Schneider E; Schreiber E; Bernhardt G; Peng S; Buschauer A
Arch Pharm (Weinheim); 2003 Dec; 336(12):585-90. PubMed ID: 14677152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
